| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.032 | 0.6 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |